- document
-
Wei, H. (author), Pasman, W. (author), Rubingh, C. (author), Wopereis, S. (author), Tienstra, M. (author), Schroen, J. (author), Wang, M. (author), Verheij, E. (author), van der Greef, J. (author)The prevalence of type 2 diabetes continuously increases globally. A personalized strategy applied in the pre-diabetic stage is vital for diabetic prevention and management. The personalized diagnosis of Chinese Medicine (CM) may help to stratify the diabetics. Metabolomics is regarded as a potential platform to provide biomarkers for disease...article 2012
- document
-
van Wietmarschen, H.A. (author), Reijmers, T.H. (author), van der Kooij, A.J. (author), Schroën, J. (author), Wei, H. (author), Hankemeier, T. (author), Meulman, J.J. (author), van der Greef, J. (author)Background: The future of personalized medicine depends on advanced diagnostic tools to characterize responders and non-responders to treatment. Systems diagnosis is a new approach which aims to capture a large amount of symptom information from patients to characterize relevant sub-groups. Methodology: 49 patients with a rheumatic disease were...article 2011
- document
-
van der Greef, J. (author), van Wietmarschen, H. (author), Schroën, J. (author), Wang, M. (author), Hankemeier, T. (author), Xu, G. (author), TNO Kwaliteit van Leven (author)Innovative systems approaches to develop medicine and health care are emerging from the integration of Chinese and Western medicine strategies, philosophies and practices. The two medical systems are highly complementary as the reductionist aspects of Western medicine are favourable in acute disease situations and the holistic aspects of Chinese...article 2010
- document
-
van Wietmarschen, H. (author), Yuan, K. (author), Lu, C. (author), Gao, P. (author), Wang, J. (author), Xiao, C. (author), Yan, X. (author), Wang, M. (author), Schroën, J. (author), Lu, A. (author), Xu, G. (author), van der Greef, J. (author), TNO Kwaliteit van Leven (author)BACKGROUND: Complex chronic diseases such as rheumatoid arthritis have become a major challenge in medicine and for the pharmaceutical industry. New impulses for drug development are needed. OBJECTIVE: A systems biology approach is explored to find subtypes of rheumatoid arthritis patients enabling a development towards more personalized...article 2009